Short Term trading, analysis and TLX noise - No investors keep out, page-529

Another notable point

UBS target of 1.1 billion of rev and a $26 share price or approx AUD 8 billion dollar market cap is only a rev multiple of eight.

Eli Lilly trades on a multiple of 20; being 42 billion of rev and a 840 US billion market cap

Let’s say they do 1.1 billion of rev times 20 = 22 billion market cap or approx $66 a share

Even adding no growth to the 700 mil forecast, that would put us at a 14 billion $ market cap or approx $40 a share on a 20 rev multiple

Ignoring all of the other positive irons in the fire I can’t see the thesis for being short